Nurix Therapeutics, Inc. NRIX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s common stock?
- Nurix Therapeutics, Inc. (NRIX) reported common stock of 500M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s common stock changed year-over-year?
- Nurix Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from 500M to 500M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s common stock has grown at a 563.1% compound annual growth rate (CAGR), from 39K to 500M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).